Synthetic Opioids: Navigating a Changing Landscape in the Treatment of Opioid Use Disorder
This 35-minute module focuses on how primary care providers can navigate the changing landscape of opioid use disorder in relation to synthetic opioids.
Search
Introduction to Forensic Substance Use Evaluation
ISSUP and the National Board of Forensic Evaluators (NBFE) are pleased to present their collaborative Webinar on conducting a Quality Forensic Substance Use Evaluations.
Implementation and workflow strategies for integrating digital therapeutics for alcohol use disorders into primary care: a qualitative study
Abstract
Background
Alcohol use disorders (AUD) are prevalent and often go untreated. Patients are commonly screened for AUD in primary care, but existing treatment programs are failing to meet demand. Digital therapeutics include novel...
Disruptions to U.S. local public health’s role in population-based substance use prevention and response during COVID-19
Background
COVID-19 dramatically limited the scale and scope of local health department (LHD) work, redirecting resources to the response. However, the need for essential public health services—including substance use prevention—was not...
Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes
Background
Opioid overdose remains a public health crisis in diverse communities. Between 2019 and 2020, there was an almost 40% increase in drug fatalities primarily due to opioid analogues of both stimulants and opioids. Medications for...
Severe bacterial infections in people who inject drugs: The role of injection-related tissue damage
Abstract
Background
In the context of the current U.S. injection drug use epidemic, targeted public health harm reduction strategies have traditionally focused on overdose prevention and reducing transmission of blood-borne viral...
High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder
In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of...
A US national randomized study to guide how best to reduce stigma when describing drug‐related impairment in practice and policy
Drug‐related impairment is persistently stigmatized delaying and preventing treatment engagement. To reduce stigma, various medical terms (e.g. ‘chronically relapsing brain disease’, ‘disorder’) have been promoted in diagnostic systems and among national health agencies, yet some argue that over‐medicalization of drug‐related impairment lowers prognostic optimism and reduces personal agency.
Tobacco Use Among Lesbian, Gay, Bisexual and Transgender Young Adults
It is recognised that smoking and use of tobacco products among lesbian, gay, bisexual, transgender and queer (LGBTQ) young adults is higher compared to their heterosexual and cisgender peers.
Although it is believed that within the LGBTQ...
Best Practices for Successful Reentry for People Who Have Opioid Addictions
This fact sheet describes the best practices that community-based behavioural health, and probation and parole agencies can implement to ensure that reentry for people who have opioid addictions is safe and successful.
The Link between the Marketing of Opioid Products with Mortality from Opioid-Related Overdoses
Prescription opioids are involved in 40% of all deaths from opioid overdose in the United States and are often the first opioids encountered by individuals with opioid use disorder.
Efficacy of Monthly Buprenorphine Injections for Opioid Use Disorders
Opioid use disorder is a chronic, relapsing disease and a global health burden. Treatment for OUD tends to involve a combination of medication and behavioural intervention. It is recognised that buprenorphine can alleviate opioid withdrawal...
Monitoring the Future: Teleconference Recording
Dr Nora Volkow, NIDA Director, discusses the results of the 2018 Monitoring the Future survey during a teleconference which took place on December 17, 2018.
Monitoring the Future tracks drug use trends of 8th, 10th, and 12th-grade students...
College Drinking: Prevention Perspectives
A recent video produced by Substance Abuse and Mental Health Service Administration highlights the harmful consequences of underage and excessive alcohol consumption, and provides evidence-based strategies that can be used in a university...
Webinar: Treatment and Prevention of Opioid Use Disorder: Overview
A webinar on opioid use disorder by Dr. Dennis McCarty is now available through the Addiction Technology Transfer Centre (ATTC) website.
The hour long webinar took place in April 2018 and discusses treatment and prevention. The webinar...
SAMHSA Tobacco-Free Recovery Grant 2018
The Substance Abuse and Mental Health Services Administration (SAMHSA) National Center of Excellence for Tobacco-Free Recovery Grant is now open for applications. Offering up to 5 million USD the grant can be used for a range of projects...
Annual Surveillance Report of Drug-Related Risks and Outcomes
This report presents information on four types of outcomes from the four different data sources:
- Opioid prescribing, 2006-2016, from QuintilesIMS Health®
- Drug use, misuse, and substance use disorder, 2014-2015, from the National Survey...
Association between Receptivity to Tobacco Advertising and Progression to Tobacco Use in Youth and Young Adults
A study funded by the National Institute on Drug Abuse (NIDA) has found an association with young people being exposed to adverts for electronic cigarettes (e-cigarettes) and taking up smoking later in life.
The study followed 10 989...
Medication for the Treatment of Alcohol Use Disorder
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), the Health and Human Services US Government Department (HSS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) have collaborated to create a manual on...
New Resource Centre from SAMHSA
SAMHSA has launched the new Evidence Based Resource Center which will allow practitioners to find tools, manuals, clinical practice guidelines and science based-resources.
Available directly through the SAMHSA website, the digital...
